Variability in endocrine cell identity in patients with chronic pancreatitis undergoing islet autotransplantation

Christine Beamish, A. Osama Gaber, Solmaz Afshar, Daniel W. Fraga, Dale J. Hamilton, Omaima Sabek

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Beta-cell dedifferentiation as shown by cellular colocalization of insulin with glucagon and/or vimentin, and decreased expression of MAFA and/or urocortin3 has been suggested to contribute to metabolic decompensation in type 2 diabetes, and was recently described postimplantation in islet allotransplant patients. Dysglycaemia and diabetes mellitus are often encountered preoperatively in patients undergoing pancreatectomy and islet autotransplantation (PIAT). In this series of case reports, we document variation in islet phenotypic identity in three patients with chronic pancreatitis (CP) without diabetes or significant insulin resistance who subsequently underwent PIAT. Pancreas histology was examined using colocalization of endocrine hormones, mesenchymal and pan-endocrine markers in islets, and the relative expression of MAFA and urocortin3 in insulin-expressing cells as compared to that of nondiabetic and type 2 diabetic donors. We present results of pre- and posttransplant clinical metabolic testing. Varying degrees of islet-cell dedifferentiation are identified in nondiabetic patients with CP at the time of PIAT, and may need further investigation.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
StateE-pub ahead of print - Oct 29 2018


  • autotransplantation
  • clinical research/practice
  • dedifferentiation
  • islet transplantation
  • tissue injury and repair

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)


Dive into the research topics of 'Variability in endocrine cell identity in patients with chronic pancreatitis undergoing islet autotransplantation'. Together they form a unique fingerprint.

Cite this